Phosphodiesterases govern nuclear cAMP signaling for gene expression
磷酸二酯酶控制基因表达的核 cAMP 信号传导
基本信息
- 批准号:10717183
- 负责人:
- 金额:$ 61.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:A kinase anchoring proteinAdrenergic AgentsAdrenergic ReceptorAffectAgonistAlanineAnxietyArrestinsBindingBiosensorCell NucleusCell membraneCognitionComplexCoupledCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic NucleotidesDataDementiaDevelopmentDiseaseDopamine ReceptorEndocytosisEndosomesFamilyFibroblastsFluorescence Resonance Energy TransferG protein coupled receptor kinaseG-Protein-Coupled ReceptorsGene ExpressionGene Expression RegulationGeneticHippocampusHumanImpairmentIon ChannelKnock-outKnockout MiceLearningLiteratureMediatingMemoryMental DepressionMusMuscle CellsNeuronsNuclearNuclear ExportPhosphorylationPhysiologicalPlayPost-Traumatic Stress DisordersProtein IsoformsProteinsReceptor SignalingRegulationRodentRoleSerineShapesSignal TransductionSignaling ProteinSiteSystemTissuesTrainingTransgenic Micearrestin3beta-2 Adrenergic Receptorsbeta-adrenergic receptorbiological adaptation to stressinhibitormorris water mazenanobodiesneuronal excitabilitynoveloverexpressionphosphoric diester hydrolasereceptorrecruitresponsescaffold
项目摘要
Abstract
Studies have established the critical roles of a superfamily of phosphodiesterases (PDEs) in
hydrolyzing cAMP and its subcellular distribution. We aim to explore the role of PDEs in differential regulation
of the cAMP signals at the plasma membrane and in the nucleus. Specifically, we will uncover the regulation of
the nuclear cAMP signals under the CNS β2-adrenergic receptor (b2AR) stimulation in hippocampal (HC)
neurons during learning and memory. Interestingly, PDE4 inhibitors benefit learning and memory in rodents
and humans, indicating that PDE4 may control the βAR-induced cAMP signal in the nucleus. PDE4D isoforms
are associated with β2AR to fine-tune subcellular cAMP-PKA signals in fibroblasts and myocytes, and PDE4D5
is associated with an AKAP95/PKA complex in the nucleus. Our preliminary data show that βAR stimulation
promotes the nuclear export of PDE4D5 in HC neurons. This relocation of PDE4D5 depends on endosome
GRK-phosphorylated b2AR and is critically necessary for delivering cAMP signals into the nucleus. Besides the
GRK-phosphorylated b2AR, we have recently characterized another distinct subpopulation of b2AR that are
PKA-phosphorylated and located at the PM after agonist stimulation in HC neurons. We hypothesize that two
b2AR subpopulations synergistically promote nuclear cAMP signal by arrestin3-dependent export of PDE4D5
from the nucleus. We will characterize the mechanisms underlying the PDE4D5-dependent regulation of
nuclear cAMP signaling and gene expression and how the regulation may affect the b2AR signaling in learning
and memory (Aim 3). This proposed study will define the role of PDE4D5 in nuclear cAMP signaling, gene
expression, and learning and memory, which not only offer new strategies to treat disorders associated with
the CNS adrenergic system but also offer an example to study many other Gs-coupled receptors, such as
dopamine receptors in the regulation of gene expression.
摘要
研究已经确定了磷酸二酯酶(PDE)超家族在以下方面的关键作用:
水解cAMP及其亚细胞分布。我们的目的是探讨偏微分方程在差异调节中的作用
细胞膜和细胞核中cAMP信号的变化。具体来说,我们将揭示
中枢神经系统β_2-肾上腺素能受体(b_2AR)刺激海马(HC)核cAMP信号
神经元在学习和记忆中的作用。有趣的是,PDE 4抑制剂有利于啮齿动物的学习和记忆。
这表明PDE 4可能控制β AR诱导的细胞核cAMP信号。PDE 4D亚型
与β 2 AR相关,以微调成纤维细胞和肌细胞中的亚细胞cAMP-PKA信号,而PDE 4D 5
与细胞核中的AKAP 95/PKA复合物相关。我们的初步数据表明,βAR刺激
促进HC神经元中PDE 4D 5的核输出。PDE 4D 5的这种重新定位依赖于内体
GRK-磷酸化的b2 AR,并且是将cAMP信号传递到细胞核中所必需的。除了
GRK-磷酸化的b2 AR,我们最近表征了另一个不同的b2 AR亚群,
在HC神经元中,激动剂刺激后PKA磷酸化并定位于PM。我们假设两个
b2 AR亚群通过抑制蛋白3依赖性PDE 4D 5输出协同促进核cAMP信号
从原子核中分离出来。我们将描述PDE 4D 5依赖性调节的机制,
核cAMP信号和基因表达以及调节如何影响学习中的b2 AR信号
记忆(目标3)这项研究将确定PDE 4D 5在核cAMP信号传导中的作用,基因表达,
表达,学习和记忆,这不仅提供了新的策略,以治疗疾病相关的
中枢神经系统肾上腺素能系统,但也提供了一个例子,研究许多其他的GS-偶联受体,如
多巴胺受体在基因表达调控中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YANG K XIANG其他文献
YANG K XIANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YANG K XIANG', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10369578 - 财政年份:2021
- 资助金额:
$ 61.77万 - 项目类别:
Desensitization of beta1 adrenergic receptor-nitric oxide signaling in cardiac diseases
心脏病中β1肾上腺素受体-一氧化氮信号的脱敏
- 批准号:
10367949 - 财政年份:2021
- 资助金额:
$ 61.77万 - 项目类别:
Desensitization of beta1 adrenergic receptor-nitric oxide signaling in cardiac diseases
心脏病中β1肾上腺素受体-一氧化氮信号的脱敏
- 批准号:
10618826 - 财政年份:2021
- 资助金额:
$ 61.77万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10513328 - 财政年份:2021
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
10425249 - 财政年份:2019
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
9922716 - 财政年份:2019
- 资助金额:
$ 61.77万 - 项目类别:
Molecular Regulation of cardiac adrenergic signaling
心脏肾上腺素信号传导的分子调节
- 批准号:
10155584 - 财政年份:2019
- 资助金额:
$ 61.77万 - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
10174956 - 财政年份:2018
- 资助金额:
$ 61.77万 - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
9929881 - 财政年份:2018
- 资助金额:
$ 61.77万 - 项目类别:
Novel mechanism on subpopulation-dependent biased GPCR signaling in neurons
神经元亚群依赖性偏向 GPCR 信号传导的新机制
- 批准号:
10372289 - 财政年份:2018
- 资助金额:
$ 61.77万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 61.77万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 61.77万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 61.77万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 61.77万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 61.77万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 61.77万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 61.77万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 61.77万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 61.77万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 61.77万 - 项目类别:














{{item.name}}会员




